Neuland Laboratories Limited
NSE:NEULANDLAB.NS
12324 (INR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 15,585.805 | 11,608.985 | 9,233.341 | 9,181.767 | 7,640.258 | 6,459.802 | 5,127.69 | 5,788.854 | 5,099.701 | 4,691.51 | 4,656.933 | 4,605.865 | 4,485.03 | 3,936.9 | 2,784.21 | 3,067.22 | 2,177.03 | 2,021.7 | 1,631.553 |
| Cost of Revenue
| 7,337.967 | 6,137.853 | 5,535.02 | 5,547.189 | 4,777.947 | 4,431.563 | 3,198.611 | 3,335.779 | 3,062.969 | 3,665.539 | 2,949.926 | 3,728.31 | 3,231.88 | 3,129.91 | 2,177.45 | 2,460.15 | 1,935.52 | 1,557.23 | 723.803 |
| Gross Profit
| 8,247.838 | 5,471.132 | 3,698.321 | 3,634.578 | 2,862.311 | 2,028.239 | 1,929.079 | 2,453.075 | 2,036.732 | 1,025.971 | 1,707.007 | 877.555 | 1,253.15 | 806.99 | 606.76 | 607.07 | 241.51 | 464.47 | 907.75 |
| Gross Profit Ratio
| 0.529 | 0.471 | 0.401 | 0.396 | 0.375 | 0.314 | 0.376 | 0.424 | 0.399 | 0.219 | 0.367 | 0.191 | 0.279 | 0.205 | 0.218 | 0.198 | 0.111 | 0.23 | 0.556 |
| Reseach & Development Expenses
| 435 | 277.576 | 3.64 | 210.658 | 0 | 0 | 140.507 | 119.522 | 109.517 | 82.422 | 108.262 | 90.26 | 0 | 0 | 0 | 0 | 59.69 | 52.11 | 37.609 |
| General & Administrative Expenses
| 309.172 | 298.914 | 156.926 | 134.892 | 147.982 | 126.719 | 178.752 | 125.851 | 98.295 | 65.549 | 34.26 | 24.292 | 0 | 362.37 | 367.03 | 348.95 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 339.358 | 295.793 | 274.019 | 346.323 | 183.019 | 182.782 | 140.359 | 111.584 | 0 | 313.325 | 265.705 | 135.118 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,579.829 | 594.707 | 430.945 | 339.725 | 331.001 | 309.501 | 319.111 | 237.435 | 98.295 | 378.874 | 299.965 | 305.96 | 0 | 362.37 | 367.03 | 348.95 | -57.82 | 278.69 | 224.895 |
| Other Expenses
| 0 | 2,255.435 | 2,302.833 | 1,987.861 | 2,285.193 | 1,850.63 | 0 | 0 | 1,195.217 | 0 | 23.16 | 7.72 | 922.67 | 120.72 | 101.44 | 36.04 | 28.91 | -0.65 | -20.466 |
| Operating Expenses
| 2,929.746 | 3,127.718 | 2,737.418 | 2,538.244 | 2,616.194 | 2,160.131 | 1,195.939 | 2,321.796 | 1,290.255 | 1,161.309 | 922.824 | 1,088.964 | 922.67 | 483.09 | 468.47 | 384.99 | 30.78 | 330.15 | 282.97 |
| Operating Income
| 5,318.092 | 2,343.414 | 960.903 | 1,096.334 | 735.987 | 384.476 | 299.771 | 881.997 | 649.864 | 523.288 | 559.628 | 442.767 | 330.48 | 323.9 | 138.29 | 222.08 | 151.04 | 134.32 | 138.213 |
| Operating Income Ratio
| 0.341 | 0.202 | 0.104 | 0.119 | 0.096 | 0.06 | 0.058 | 0.152 | 0.127 | 0.112 | 0.12 | 0.096 | 0.074 | 0.082 | 0.05 | 0.072 | 0.069 | 0.066 | 0.085 |
| Total Other Income Expenses Net
| -1,303.727 | -185.95 | -139.278 | -42.999 | -206.762 | -181.103 | -160.427 | -210.14 | -229.835 | -276.07 | -214.093 | -253.503 | -234.71 | -274.73 | -236.43 | -75.95 | -45.92 | -35.71 | -52.332 |
| Income Before Tax
| 4,014.365 | 2,157.464 | 821.625 | 1,053.335 | 529.225 | 203.373 | 139.344 | 671.857 | 420.029 | 247.218 | 345.535 | 189.264 | 95.77 | 49.17 | -98.14 | 146.13 | 105.12 | 98.61 | 85.881 |
| Income Before Tax Ratio
| 0.258 | 0.186 | 0.089 | 0.115 | 0.069 | 0.031 | 0.027 | 0.116 | 0.082 | 0.053 | 0.074 | 0.041 | 0.021 | 0.012 | -0.035 | 0.048 | 0.048 | 0.049 | 0.053 |
| Income Tax Expense
| 1,013.576 | 522.288 | 183.405 | 247.028 | 367.12 | 38.957 | 18.715 | 203.211 | 149.235 | 87.897 | 77.997 | 28.08 | -17.39 | -3.51 | -28.93 | 26.93 | -8.4 | 8.23 | 23.52 |
| Net Income
| 3,000.789 | 1,635.176 | 638.22 | 806.307 | 162.105 | 164.416 | 120.629 | 468.646 | 273.245 | 159.469 | 268.073 | 138.63 | 25.61 | 52.89 | -69.05 | 119.23 | 113.52 | 90.38 | 62.361 |
| Net Income Ratio
| 0.193 | 0.141 | 0.069 | 0.088 | 0.021 | 0.025 | 0.024 | 0.081 | 0.054 | 0.034 | 0.058 | 0.03 | 0.006 | 0.013 | -0.025 | 0.039 | 0.052 | 0.045 | 0.038 |
| EPS
| 233.89 | 127.45 | 49.74 | 62.85 | 12.63 | 13.06 | 10.81 | 42.01 | 30.76 | 18.67 | 33.84 | 17.33 | 4.05 | 8.06 | -10.57 | 18.24 | 17.38 | 13.83 | 9.44 |
| EPS Diluted
| 233.89 | 127.45 | 49.74 | 62.85 | 12.63 | 13.06 | 10.81 | 42.01 | 30.75 | 18.66 | 33.83 | 17.31 | 4.04 | 8.05 | -10.57 | 18.21 | 17.38 | 13.83 | 9.44 |
| EBITDA
| 4,748.184 | 2,791.761 | 1,404.028 | 1,629.144 | 1,003.558 | 561.118 | 490.976 | 1,009.459 | 734.914 | 583.687 | 664.795 | 588.995 | 480.21 | 478.01 | 273.89 | 295.78 | 222 | 193.55 | 188.971 |
| EBITDA Ratio
| 0.305 | 0.24 | 0.152 | 0.177 | 0.131 | 0.087 | 0.096 | 0.174 | 0.144 | 0.124 | 0.143 | 0.128 | 0.107 | 0.121 | 0.098 | 0.096 | 0.102 | 0.096 | 0.116 |